Intravesical gemcitabine, docetaxel effective for recurrent nonmuscle invasive bladder cancer
Intravesical gemcitabine and docetaxel is an effective and well-tolerated rescue therapy, delivering a durable response in patients with recurrent nonmuscle invasive bladder cancer and a history of bacillus Calmette-Guérin treatment, a recent study has shown.
Intravesical gemcitabine, docetaxel effective for recurrent nonmuscle invasive bladder cancer
26 Apr 2020